In light of the coverage trends and other ACA-related changes, this paper describes the impact on women and their partners, as well as family planning providers, of the impact of family planning expansion programs under Medicaid. It is based largely on interviews with state officials, providers and consumer advocates in Alabama, California, Connecticut, Illinois, Missouri and Virginia – a cross-section of states in terms of geography, Medicaid expansion status, and implementation of a Medicaid family planning program. State interviews were supplemented by interviews with national experts, policymakers and family planning provider organizations. This study was conducted in Summer 2016 before the Presidential election.
- view as grid
- view as list
Three quarters of reproductive age women on Medicaid are enrolled in managed care arrangements. This analysis explores the experiences and perspectives of leaders of Medicaid Managed Care Organizations (MCOs) in structuring their networks and services to provide family planning and reproductive health services to women. It finds that MCOs rely heavily on safety net clinics including Community Health Centers and Family Planning Clinics such as Planned Parenthood to provide in-network family planning services to their members. MCO leaders also identified churning in enrollment, the high costs of stocking IUDs and implants, global hospital payment methodologies for maternity care, and the inclusion of faith-based providers in plan networks as potential barriers to certain family planning services.
Repeal of the Affordable Care Act could have a profound impact on women, as the law fundamentally changed women’s health coverage, benefits, and access to care. In a new issue brief, the Kaiser Family Foundation outlines 10 ways women could be affected if the ACA is repealed or its provisions…
Web Briefing for Journalists – Potential Changes to Health Care Access and Coverage: What’s at Stake for Women?
House Republicans’ American Health Care Act and other actions under discussion by President Donald Trump’s administration and the new Congress could profoundly affect access to health care for many women. Repeal of the Affordable Care Act, changes to its birth control coverage provision, and new state and federal abortion restrictions,…
This fact sheet examines the U.S. government’s role in family planning and reproductive health worldwide.
On January 23, President Donald Trump reinstated the Mexico City Policy, which stipulates that in order to receive U.S. global health funding, foreign non-governmental organizations (NGOs) must certify that they will not perform or actively promote abortion as a method of family planning using funds from any source. A new explainer…
The Affordable Care Act’s contraceptive coverage provision made access to the full range of contraceptive methods available to millions of women with private insurance at no cost. Despite broad public support, this provision has been challenged by religious employers, with two cases reaching the Supreme Court. It is unclear how…
This issue brief explains the Affordable Care Act’s current contraceptive coverage rule, the impact it has had on women, and the state of contraceptive coverage if the rule is eliminated or modified.
Oral contraceptives are now the most widely used form of contraception. In the U.S., the daily oral contraceptive pills have traditionally only been available with a prescription, but current legislative and advocacy efforts in some states have focused on broadening access to oral contraceptives by eliminating the requirement that women first have an in-person clinical visit. This factsheet provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews emerging strategies to promote and expand women’s access to oral contraceptives.
Insurance coverage of contraceptive services has been the focus of policy attention by state and federal policymakers, as well as in the courts, over the past two decades. This issue brief explains the rules for private insurance coverage of contraceptives at the federal and state level and discusses key issues regarding the provision and coverage of contraception by private insurance plans, including the impact of the Affordable Care Act (ACA).